Smoking Cessation Counseling Performance Among Medical Interns

NCT07650721 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 140

Last updated 2026-08-19

No results posted yet for this study

Summary

Smoking remains one of the leading preventable causes of morbidity and mortality worldwide and is strongly associated with chronic respiratory diseases, cardiovascular disease, cancer, and premature death. Physicians play a central role in tobacco control through the delivery of smoking cessation counseling, and even brief physician advice has been shown to significantly increase smoking quit rates. The evidence-based 5A's model (Ask, Advise, Assess, Assist, and Arrange) is widely recommended as the standard framework for smoking cessation counseling.

Conditions

  • Smoking Cessation

Interventions

DEVICE

Artificial Intelligence assisted interactive case-based training for smoking cessation counselling

Participants will receive AI-assisted interactive case-based training in addition to the standard educational materials. The intervention will consist of a series of standardized clinical scenarios related to smoking cessation counseling, followed by structured AI-generated educational feedback based on the 5A model

DEVICE

standard guideline-based smoking cessation training

Participants will receive standard guideline-based smoking cessation training consisting of educational materials covering the 5A smoking cessation counseling model, nicotine dependence, pharmacological treatment options, and smoking cessation referral strategies.

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • waleed gamal, ass. prof · Assiut University

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-06-30
Primary Completion
2026-09-01
Completion
2026-10-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07650721 on ClinicalTrials.gov